Aileron Therapeutics, Inc.ALRNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank92
3Y CAGR+80.9%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+80.9%/yr
vs -2.7%/yr prior
Acceleration
+83.7pp
Accelerating
Percentile
P92
Near historical high
vs 3Y Ago
5.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1.88M-15.5%
2024$2.23M+309.7%
2023$544000.00+71.1%
2022$318000.00-27.9%
2021$441000.00+166.7%
2020$-661000.00-212.6%
2019$587000.00+65.4%
2018$355000.00-12.1%
2017$404000.00+778.3%
2016$46000.00-